Adenylyl cyclases are central to one of the most important transmembrane signal transduction pathways in virtually all biological systems and constitute a family of isozymes catalyzing the formation of adenosine 3': 5'-monophosphate (cAMP) from 5'ATP. Mammalian forms of the enzyme are stimulated or inhibited by hormones via G-protein-linked cell-surface receptors and are inhibited by intracellular adenine nucleoside 3'-phosphates via an enzyme conformation that is distinct from that through which catalysis occurs. The proposal is based on observations made with and unique applications for conformation-specific inhibitors of adenylyl cyclases we have synthesized: a) competitive inhibitors targeting the pre-transition, catalytically competent conformation, exemplified by b-L-2',3'-dideoxyadenosine-5'-triphosphate (IC50 about 24nM), and b) non-competitive inhibitors targeting the post-transition product leaving conformation, exemplified by 2',5'-dideoxyadenosine-3'-triphosphate (IC50 about 40nM). The goals of the proposed investigations include: i) to use these ligands and derivatives of them to define structural differences between pre- and post-transition configurations of adenylyl cyclase and differences among selected wild type and mutated adenylyl cyclase isozymes, by biochemical and biophysical techniques; ii) to establish in intact cells and tissues the consequences of adenylyl cyclase inhibition by prodrug derivatives of these nucleotides; iii) to identify and quantify naturally occurring adenine nucleoside 3'-polyphosphates and to identify the pathways of their synthesis and degradation; and iv) to isolate other enzymes through which they may act to alter cell function. The proposed approaches build on the applicant's experience with adenylyl cyclases, with its regulation by adenine nucleotides, and with the synthesis of unique, labeled and unlabeled nucleotide derivatives targeted to specific configurations of this key transmembrane signal transduction enzyme. The proposed studies will provide unique ligands and approaches to address key questions regarding the structure and regulation of adenylyl cyclases, will establish previously unexplored links between cell-initiated regulation of adenylyl cyclases and 3'-nucleotide metabolism, and will lead to the identification of other target proteins with which adenine nucleoside 3'-polyphosphates interact and regulate.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK038828-14
Application #
6380572
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Abraham, Kristin M
Project Start
1986-09-01
Project End
2004-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
14
Fiscal Year
2001
Total Cost
$386,025
Indirect Cost
Name
State University New York Stony Brook
Department
Physiology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Laux, Wolfgang H G; Pande, Praveen; Shoshani, Ilana et al. (2004) Pro-nucleotide inhibitors of adenylyl cyclases in intact cells. J Biol Chem 279:13317-32
Shoshani, I; Taussig, R; Iyengar, R et al. (2000) Synthesis and use of 3'-(azidoiodosalicyl) derivatives of 2', 5'-dideoxyadenosine as photoaffinity ligands for adenylyl cyclase. Arch Biochem Biophys 376:221-8
Tesmer, J J; Dessauer, C W; Sunahara, R K et al. (2000) Molecular basis for P-site inhibition of adenylyl cyclase. Biochemistry 39:14464-71
Shoshani, I; Bianchi, G; Desaubry, L et al. (2000) Lys-Ala mutations of type I adenylyl cyclase result in altered susceptibility to inhibition by adenine nucleoside 3'-polyphosphates. Arch Biochem Biophys 374:389-94
Shoshani, I; Laux, W H; Perigaud, C et al. (1999) Inhibition of adenylyl cyclase by acyclic nucleoside phosphonate antiviral agents. J Biol Chem 274:34742-4
Doronin, S; Murray, L; Dessauer, C W et al. (1999) Covalent labeling of adenylyl cyclase cytosolic domains with gamma-methylimidazole-2',5'-dideoxy-[gamma-(32)P]3'-ATP and the mechanism for P-site-mediated inhibition. J Biol Chem 274:34745-50
Szczepanik, M B; Desaubry, L; Johnson, R A (1999) Synthesis of nucleoside 3'-thiophosphates in one step procedure. Nucleosides Nucleotides 18:951-3
Johnson, R A; Shoshani, I; Dessauer, C et al. (1999) Enzymatic preparation of 32P-labeled beta-L-2',3',-dd-5'ATP and its use as a high-affinity, conformation-specific ligand for labeling adenylyl cyclases. Nucleosides Nucleotides 18:839-42
Tesmer, J J; Sunahara, R K; Johnson, R A et al. (1999) Two-metal-Ion catalysis in adenylyl cyclase. Science 285:756-60
Ibrahimi, A; Abumrad, N; Maghareie, H et al. (1999) Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. Am J Physiol 276:C487-96

Showing the most recent 10 out of 28 publications